↓ Skip to main content

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Overview of attention for article published in BMC Cancer, March 2022
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
20 Mendeley